PMIHealthcare · Medical Devices

PMI Stock Forecast: Picard Medical, Inc. Price Predictions for 2026-2027

Last close, 11 Sept 2026

$5.33

+20.86% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 25 of 100 as at 12 Sept 2026 — in the lower half.

Market cap

$10.9M

Ticker Nerd rank

25 / 100

Median analyst target

—

Analysts covering

Revenue$3.0M+38.6% y/y

Operating income−$4.6M

Net income−$5.7M

Free cash flow−$1.4M

Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown

Total return, dividends reinvested

+18.7%

+46.8%

YTD

−93.9%

−98.5%

From 52W high

−99.2%

From 52W low

+75.9%

$660

52-week range, adjusted closes · the dot is the last close

Ticker Nerd rank

PMI stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Picard Medical, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 12 Sept 2026

25 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size

Accruals

Issuance

Growth

Revisions

Volatility

Value

Momentum

Quality

Size (91): Smaller than most of the companies we track.

Quality (6): Profits are thin or unreliable for the size of the business, or they are not turning into cash.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

PMI stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on PMI, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says1 analysts

0 Buy1 Hold0 Sell

Recent analyst actionsNewest first

Date	Firm	Action	Rating	Target
3 June 2026	HC Wainwright & Co.	Reiterates	Neutral	—
18 May 2026	HC Wainwright & Co.	Initiates	Neutral	—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. PMI appears on the weeks it earns a place.

Performance

PMI vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 11 Sept 2026, Picard Medical, Inc. returned −98.5% against +17.5% for the S&P 500, dividends included.

PMI vs S&P 500, last 12 monthsTotal return, rebased to 100

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

PMI analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year

Analysts raising

Analysts cutting

Fundamentals

Picard Medical, Inc. (PMI) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: −0.1×
Price / sales: 2.0×
Price / book: 6.4×
EV / EBITDA: −0.9×

Growth & margins

Revenue growth (YoY): 38.6%
Earnings growth (YoY): —
Gross margin: 20.9%
Operating margin: −156.7%
Net margin: −4.1%

Returns & dividend

Return on equity: −712.6%
Return on assets: −93.6%
Dividend yield: —

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Picard Medical, Inc. (PMI) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

Picard Medical, Inc. has a market value of $10.9M and an enterprise value of $14.0M.
Revenue in the twelve months to 30 June 2026: $6.3M. The latest quarter grew 38.6% year on year.
Net income over the same four quarters: −$28.0M, a −444.3% net margin.
Free cash flow in the twelve months to 30 June 2026: −$16.1M.
Shares outstanding: 2.1M.
Trailing P/E: −0.1×; forward P/E: −1.2× — the forward figure prices analyst consensus estimates, not reported earnings.
Picard Medical, Inc. employs 75 people — $84K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 14 Sept 2026

Data provided by Twelve Data

Peers

PMI vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices

Company	Market cap	TKN rank
PMIPicard Medical, Inc.	$10.9M	25
ADGMAdagio Medical Holdings, Inc.	$11.9M	37
HSCSHeartSciences, Inc.	$13.2M	31
SINTSINTX Technologies, Inc.	$11.4M	27
IRIXIRIDEX Corp.	$11.3M	80
NMTCNeuroOne Medical Technologies Corp.	$14.2M	39
BMRABiomerica, Inc.	$10.3M	17

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Picard Medical, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest PMI news & analysis

Picard Medical Reports Second Quarter 2026 Financial Results

GlobeNewsWire · 19 Aug 2026positive

Picard Medical, Inc. reported its financial results for the second quarter ended June 30, 2026, showing a 39% increase in revenue and a 16% decrease in net loss. Year-to-date revenue rose 50%, with approximately $0.9 million in gross profit.

Why it matters — PMI watchers would care because the company reported higher revenue and a reduced net loss, indicating improving financial performance for the maker of the total artificial heart.

Picard Medical / SynCardia Presents Emperor Total Artificial Heart Architecture for the First Time at IEEE EMBC 2026

GlobeNewsWire · 31 July 2026positive

Picard Medical/SynCardia presented the architecture of its Emperor Total Artificial Heart for the first time at the IEEE EMBC 2026 conference, marking the initial public scientific disclosure of its next-generation total artificial heart platform.

Why it matters — This first detailed public presentation signals a significant research and development milestone for PMI's total artificial heart program, offering the biomedical community an early look at the platform.

Picard Medical / SynCardia to Present Next-Generation Emperor Total Artificial Heart Technology at IEEE EMBC 2026

GlobeNewsWire · 27 July 2026positive

Picard Medical and its subsidiary SynCardia announced that the next-generation Emperor Total Artificial Heart technology will be presented at the IEEE EMBC 2026 conference in Toronto, marking the first scientific presentation of the Emperor Drive System architecture to the biomedical engineering community.

Why it matters — This presentation signals progress in the development of Picard's next-generation artificial heart technology, which could expand the company's product pipeline beyond its currently approved total artificial heart.

Picard Medical Receives NYSE American Acceptance of Compliance Plan

GlobeNewsWire · 27 July 2026positive

Picard Medical announced that the NYSE American has accepted the company's compliance plan. The company said it continues advancing its long-term growth strategy under the accepted plan.

Why it matters — Acceptance of the compliance plan by NYSE American removes a potential delisting risk and allows Picard Medical to focus on its long-term growth strategy without exchange-listing uncertainty.

FAQ

Frequently asked questions about PMI stock

Is PMI stock a buy right now?

Of the 1 analysts covering Picard Medical, Inc., 0 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Picard Medical, Inc. 25 out of 100 across roughly 4,600 US stocks as at 12 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank PMI?

As at 12 Sept 2026, Picard Medical, Inc. ranks 25 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (91 of 100).

What is the PMI stock forecast for 2030?

No analyst covering Picard Medical, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for PMI are extrapolating price history, which says nothing about the business.

How has PMI stock performed over the past year?

Picard Medical, Inc. returned -98.5% over the 12 months to 11 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Picard Medical, Inc. do?

What is the latest news on PMI?

The most recent item we track (GlobeNewsWire, 19 Aug 2026): "Picard Medical Reports Second Quarter 2026 Financial Results". Picard Medical, Inc. reported its financial results for the second quarter ended June 30, 2026, showing a 39% increase in revenue and a 16% decrease in net loss. Year-to-date revenue rose 50%, with approximately $0.9 million in gross profit.

Company

About Picard Medical, Inc.

Picard Medical Inc. is a medical technology company focused on designing, manufacturing, and commercializing the SynCardia Total Artificial Heart, an implantable device used for patients with advanced heart failure. Through its subsidiary SynCardia Systems, the company develops and supplies total artificial heart therapy products that support patients who need temporary or bridge-to-transplant cardiac replacement options. Its business is centered on medical device production, marketing, and distribution across the United States, Europe, and other international markets. Based in Tucson, Arizona, Picard Medical Inc. plays a specialized role in the healthcare equipment sector by addressing a highly critical segment of cardiac support and artificial organ technology.

CEO Dr. Yuncai Fang Ph.D. · 75 employees · United States · https://www.picardmedical.com